Literature DB >> 24826792

α-Globin gene mutations in Isfahan Province, Iran.

Arezo Karamzade1, Hadi Mirzapour, Majid Hoseinzade, Sara Asadi, Tahere Gholamrezapour, Parvaneh Tavakoli, Mansoor Salehi, Mansoor Selebi.   

Abstract

α-Thalassemia (α-thal) encompasses a spectrum of mutations including deletion and point mutations on the α-globin chains that is characterized by a reduction or complete absence of α-globin genes. Most of the α-thal cases are deletions involving one (α(+)) or both (α(0)) α-globin genes, although point mutations (α(T)α or αα(T)) are found as well. In this study, 314 individuals with low hematological values, normal Hb A2 who were not affected with β-thal or iron deficiency, were investigated for the presence of α-thal mutations. The most common deletion was -α(3.7) (rightward) with a frequency of 70.7%, followed by α(-5 nt) (-TGAGG) (8.7%), -α(4.2) (leftward) (4.7%), the polyadenylation signal (polyA2) site (AATAAA > AATGAA) (4.2%), -(α)(20.5) (3.8%), Hb Constant Spring [Hb CS, α142, Stop→Gln; HBA2: c.427T > C] (2.9%), polyA1 (AATAAA > AATAAG) and α(codon 19) (GCG > GC-, α2) (16%), and - -(MED) (0.9%). The results of this study may be valuable for designing a plan for carrier screening, premarital genetic counseling, prenatal diagnosis (PND) and reducing excessive health care costs to an affordable level in Isfahan Province, Iran.

Entities:  

Keywords:  Iran; Isfahan Province; mutations; α-Thalassemia (α-thal)

Mesh:

Substances:

Year:  2014        PMID: 24826792     DOI: 10.3109/03630269.2014.893531

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Iranian patients with hemoglobin H disease: genotype-phenotype correlation.

Authors:  Mostafa Paridar; Ebrahim Azizi; Bijan Keikhaei; Vahideh Takhviji; Iman Baluchi; Abbas Khosravi
Journal:  Mol Biol Rep       Date:  2019-07-04       Impact factor: 2.316

2.  Detection of Common Deletional of α-Thalassemia 3.7 Kb from Metropolitan Region of Manaus, Amazonas, Brazil.

Authors:  Fernanda Cozendey Anselmo; Abdou Gafar Soumanou; Cleidiane de Aguiar Ferreira; Flora Maia Viga Sobrinha; Ana Caroline Santos Castro; Rafael Oliveira Brito; Adolfo José da Mota; Marilda de Souza Gonçalves; José Pereira de Moura Neto
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

3.  Molecular Basis of α-Thalassemia in Iran

Authors:  Atefeh Valaei; Morteza Karimipoor; Alireza Kordafshari; Sirous Zeinali
Journal:  Iran Biomed J       Date:  2018-01-01

Review 4.  Hemoglobinopathies in Iran: An Updated Review.

Authors:  Abolfazl Nasiri; Zohreh Rahimi; Asad Vaisi-Raygani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.